BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 26725072)

  • 1. Validation of the diagnostic and prognostic relevance of serum MMP-7 levels in renal cell cancer by using a novel automated fluorescent immunoassay method.
    Niedworok C; vom Dorp F; Tschirdewahn S; Rübben H; Reis H; Szucs M; Szarvas T
    Int Urol Nephrol; 2016 Mar; 48(3):355-61. PubMed ID: 26725072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated serum matrix metalloproteinase 7 levels predict poor prognosis after radical prostatectomy.
    Szarvas T; Becker M; Vom Dorp F; Meschede J; Scherag A; Bánkfalvi A; Reis H; Schmid KW; Romics I; Rübben H; Ergün S
    Int J Cancer; 2011 Mar; 128(6):1486-92. PubMed ID: 20473942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of pro-MMP-7 as a serum marker for renal cell carcinoma by use of proteomic analysis.
    Sarkissian G; Fergelot P; Lamy PJ; Patard JJ; Culine S; Jouin P; Rioux-Leclercq N; Darbouret B
    Clin Chem; 2008 Mar; 54(3):574-81. PubMed ID: 18202161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma matrix metalloproteinase-7 as a metastatic marker and survival predictor in patients with renal cell carcinomas.
    Ramankulov A; Lein M; Johannsen M; Schrader M; Miller K; Jung K
    Cancer Sci; 2008 Jun; 99(6):1188-94. PubMed ID: 18422740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic Role of Matrix Metalloproteinases 2, 7, 8, 9 and Their Type 1 Tissue Inhibitor in Blood Serum of Patients with Kidney Cancer.
    Kushlinskii NE; Gershtein ES; Alferov AA; Bezhanova SD; Mushtenko VV; Pushkar DY; Matveev VB; Stilidi IS
    Bull Exp Biol Med; 2020 Mar; 168(5):673-676. PubMed ID: 32248449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of matrix metalloproteinase-7 on cancer cells and tissue endothelial cells in renal cell carcinoma: prognostic implications and clinical significance for invasion and metastasis.
    Miyata Y; Iwata T; Ohba K; Kanda S; Nishikido M; Kanetake H
    Clin Cancer Res; 2006 Dec; 12(23):6998-7003. PubMed ID: 17145820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantification of carbonic anhydrase IX expression in serum and tissue of renal cell carcinoma patients using enzyme-linked immunosorbent assay: prognostic and diagnostic potentials.
    Zhou GX; Ireland J; Rayman P; Finke J; Zhou M
    Urology; 2010 Feb; 75(2):257-61. PubMed ID: 19963243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating Anti-Matrix Metalloproteinase-7 Antibodies May Be a Potential Biomarker for Oral Squamous Cell Carcinoma.
    Jiang T; Xie P; Liu H
    J Oral Maxillofac Surg; 2016 Mar; 74(3):650-7. PubMed ID: 26454036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significance of circulating matrix metalloproteinase-9 to tissue inhibitor of metalloproteinases-2 ratio as a predictor of disease progression in patients with metastatic renal cell carcinoma receiving sunitinib.
    Miyake H; Nishikawa M; Tei H; Furukawa J; Harada K; Fujisawa M
    Urol Oncol; 2014 Jul; 32(5):584-8. PubMed ID: 24680659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of serum CA9 in patients with metastatic clear cell renal cell carcinoma under targeted therapy.
    Gigante M; Li G; Ferlay C; Perol D; Blanc E; Paul S; Zhao A; Tostain J; Escudier B; Negrier S; Genin C
    Anticancer Res; 2012 Dec; 32(12):5447-51. PubMed ID: 23225450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The neutrophil gelatinase-associated lipocalin, or LCN 2, marker of aggressiveness in clear cell renal cell carcinoma].
    Perrin C; Patard JJ; Jouan F; Collet N; Théoleyre S; Edeline J; Zerrouki S; Laguerre B; Bellaud-Roturaud MA; Rioux-Leclercq N; Vigneau C
    Prog Urol; 2011 Nov; 21(12):851-8. PubMed ID: 22035911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the automated KRYPTOR chromogranin A assay with the DAKO ELISA.
    Wolf M; Riedlinger I; Lehmann R; Häring HU; Schleicher E; Peter A
    Clin Lab; 2014; 60(12):2103-6. PubMed ID: 25651748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of circulating MMP-7 level as an independent prognostic marker of poor survival in urinary bladder cancer.
    Szarvas T; Jäger T; Becker M; Tschirdewahn S; Niedworok C; Kovalszky I; Rübben H; Ergün S; vom Dorp F
    Pathol Oncol Res; 2011 Jun; 17(2):325-32. PubMed ID: 21253919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating matrix metalloproteinase-7: an early or metastatic marker for renal cell carcinoma?
    Jung K; Ramankulov A; Schrader M; Miller K; Lein M
    Clin Chem; 2008 Nov; 54(11):1927-9. PubMed ID: 18957565
    [No Abstract]   [Full Text] [Related]  

  • 15. Matrix Metalloproteinase-13 - A Potential Biomarker for Detection and Prognostic Assessment of Patients with Esophageal Squamous Cell Carcinoma.
    Sedighi M; Aledavood SA; Abbaszadegan M; Memar B; Montazer M; Rajabian M; Gholamin M
    Asian Pac J Cancer Prev; 2016; 17(6):2781-5. PubMed ID: 27356690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of matrix metalloproteinase-10 in renal cell carcinoma and its prognostic role.
    Miyata Y; Iwata T; Maruta S; Kanda S; Nishikido M; Koga S; Kanetake H
    Eur Urol; 2007 Sep; 52(3):791-7. PubMed ID: 17207914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum matrix metalloproteinase-9 in head and neck squamous cell carcinoma is a prognostic marker.
    Ruokolainen H; Pääkkö P; Turpeenniemi-Hujanen T
    Int J Cancer; 2005 Sep; 116(3):422-7. PubMed ID: 15818624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical significance of serum matrix metalloproteinase-13 levels in patients with esophageal squamous cell carcinoma (ESCC).
    Jiao XL; Chen D; Wang JG; Zhang KJ
    Eur Rev Med Pharmacol Sci; 2014; 18(4):509-15. PubMed ID: 24610617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum metalloproteinases 1 and 7 in the diagnosis of idiopathic pulmonary fibrosis and other interstitial pneumonias.
    Morais A; Beltrão M; Sokhatska O; Costa D; Melo N; Mota P; Marques A; Delgado L
    Respir Med; 2015 Aug; 109(8):1063-8. PubMed ID: 26174192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum matrix metalloproteinase 7 levels identifies poor prognosis advanced colorectal cancer patients.
    Maurel J; Nadal C; Garcia-Albeniz X; Gallego R; Carcereny E; Almendro V; Mármol M; Gallardo E; Maria Augé J; Longarón R; Martínez-Fernandez A; Molina R; Castells A; Gascón P
    Int J Cancer; 2007 Sep; 121(5):1066-71. PubMed ID: 17487834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.